M. Kuwana, J. Kaburaki, T. Mimori, T. Tojo, M. Homma et al., Autoantibody reactive with three 117 classes of RNA polymerases in sera from patients with systemic sclerosis classification criteria for systemic sclerosis: an American College of 121, J Clin Invest, vol.11891, pp.1399-404, 1993.

V. Sobanski, L. Dauchet, G. Lefèvre, M. Lambert, S. Morell-dubois et al., Prevalence 124 of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French 125 cohort and a systematic review and meta-analysis, Arthritis Rheumatol Hoboken NJ, vol.12666, pp.407-424, 2014.

B. Faucher, P. Stein, B. Granel, P. Weiller, P. Disdier et al., Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population, European Journal of Internal Medicine, vol.21, issue.2, pp.114-121, 2010.
DOI : 10.1016/j.ejim.2010.01.004

J. Parker, R. Burlingame, T. Webb, and C. Bunn, Anti-RNA polymerase III antibodies 132 in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA, p.133
DOI : 10.1093/rheumatology/ken201
URL : https://academic.oup.com/rheumatology/article-pdf/47/7/976/5068277/ken201.pdf

V. Codullo, G. Morozzi, A. Bardoni, R. Salvini, G. Deleonardi et al., Validation 146 of a new immunoenzymatic method to detect antibodies to RNA polymerase III in 147 systemic sclerosis, Clin Exp Rheumatol, vol.25, pp.373-380, 2007.

Y. Yamasaki, M. Honkanen-scott, L. Hernandez, K. Ikeda, T. Barker et al., Nucleolar staining cannot be used as a screening test for the scleroderma marker anti???RNA polymerase I/III antibodies, Arthritis & Rheumatism, vol.105, issue.9, pp.3051-3057, 2006.
DOI : 10.7326/0003-4819-119-10-199311150-00007
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.22043/pdf